Search

Search Constraints

You searched for: Author/Creator Hurvitz, S.A.

Search Results

1. Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial. (November 2018)

2. Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study. (August 2016)

3. Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study. (August 2016)